Work

Abstract 3478: Pre-clinical characterization of AZD0240, a CRISPR-engineered autologous TCR-T cell product targeting KRAS-G12D/HLA-A*11:01 that is multi-armored to increase epitope sensitivity

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3478

Authors: Lianne Kok, Sander Eshuis, Xiangjun Kong, Jennifer Ma, Michelle Mojadidi, Paula Kroon, Vanessa Tubb, Ton Schumacher, Arianne Perez, Carsten Linnemann, Mark Cobbold, Jeroen van Heijst, Gavin Bendle

Institutions: AstraZeneca (Netherlands), AstraZeneca (United States), The Netherlands Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409630482

Cites:

Cited by: 1

Related to: 10